longterm 1
safety 1
efficacy 1
dalfampridine 3
walking 1
impairment 1
patients 2
multiple 5
sclerosis 5
results 1
openlabel 1
extensions 1
phase 3
clinical 2
trials 2
pooled 1
analysis 1
trial 3
extended 1
release 1
oral 2
sustainedrelease 2
fampridine 2
randomised 1
doubleblind 1
controlled 1
dose 1
comparison 1
